Waldencast PLC: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Waldencast PLC Unternehmen

Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. Obagi Medical sells skin care products which are formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, wrinkles, and to protect and enhance skin tone and texture. It offers over 125 products in the United States through various channels. The Milk Makeup segment is a makeup brand which offers a selection of both makeup and skincare products. Its products include Matte Bronzer, Hydro Grip Set + Refresh Spray, Kush Mascara, Kush Brow, Water Jelly Tint, and Hydro Grip Primer. Milk Makeup offers over 250 products through its United States Website, www.MilkMakeup.com, and its retail partners, including Sephora in North America, Europe, the Middle East, Australia, Cult Beauty, and ASOS online.

Unternehmensinformationen

Unternehmens-codeWALD

Name des UnternehmensWaldencast PLC

IPO-datumMar 18, 2021

Gegründet am2020

CEOMr. Michel Brousset

Anzahl der mitarbeiter332

WertpapierartOrdinary Share

GeschäftsjahresendeMar 18

Addresse81 Fulham Road

StadtLONDON

BörseNASDAQ Capital Market Consolidated

LandUnited Kingdom

PostleitzahlSW3 6RD

Telefon4402031960264

Websitehttps://www.waldencast.com/

Unternehmens-codeWALD

IPO-datumMar 18, 2021

Gegründet am2020

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Michel Brousset

Chief Executive Officer, Director

2.90M

--

Ms. Lindsay Pattison

Independent Director

20.00K

--

Ms. Hind Sebti

Chief Growth Officer, Director

20.00K

--

Mr. Aaron Chatterley

Independent Director

20.00K

--

Ms. Juliette Hickman

Independent Director

20.00K

--

Mr. Manuel Manfredi

Chief Financial Officer

--

Mr. Simon Dailley

Director

--

Mr. Zachary (Zack) Werner

Independent Director

--

Ms. Kelly Brookie

Independent Director

--

Mr. Felipe Dutra

Executive Chairman of the Board

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Michel Brousset

Chief Executive Officer, Director

2.90M

--

Ms. Lindsay Pattison

Independent Director

20.00K

--

Ms. Hind Sebti

Chief Growth Officer, Director

20.00K

--

Mr. Aaron Chatterley

Independent Director

20.00K

--

Ms. Juliette Hickman

Independent Director

20.00K

--

Mr. Manuel Manfredi

Chief Financial Officer

--

Umsatzaufteilung

Währung: USDUpdate-Zeit: Sun, Apr 6

FY2024

FY2023

FY2022

FY2022Q2

FY2022Q1

FY2021

FY2021Q4

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product sales

269.37M

98.36%

Royalties

4.50M

1.67%

Nach RegionUSD

Name

Umsatz

Anteil

North America

202.26M

75.09%

Rest of the World

67.11M

24.91%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product sales

269.37M

98.36%

Royalties

4.50M

1.67%

Aktionäre

Update-Zeit: Wed, Apr 16

Aktionärsstatistik

Art

Aktionärsstatistik

Aktionäre

Anteil

Cedarwalk Skincare Ltd

25.56%

Zeno Equity Partners LLP

13.01%

Arbitrage Ltd

8.92%

Waldencast Long-Term Capital LLC

8.31%

Burwell Mountain Trust

7.00%

Other

37.19%

Aktionärsstatistik

Aktionäre

Anteil

Cedarwalk Skincare Ltd

25.56%

Zeno Equity Partners LLP

13.01%

Arbitrage Ltd

8.92%

Waldencast Long-Term Capital LLC

8.31%

Burwell Mountain Trust

7.00%

Other

37.19%

Art

Aktionäre

Anteil

Corporation

54.55%

Hedge Fund

13.17%

Private Equity

5.43%

Investment Advisor

4.64%

Individual Investor

2.70%

Investment Advisor/Hedge Fund

1.86%

Research Firm

0.33%

Bank and Trust

0.04%

Pension Fund

0.02%

Other

17.26%

Institutionelle Beteiligung

Update-Zeit: Tue, Mar 4

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q1

144

92.73M

82.76%

-923.07K

2024Q4

144

78.12M

69.70%

-17.61M

2024Q3

135

86.17M

77.32%

-10.93M

2024Q2

172

87.50M

78.73%

-27.82M

2024Q1

176

82.86M

81.85%

-41.80M

2023Q4

166

82.66M

81.66%

-28.79M

2023Q3

155

85.92M

95.07%

-24.54M

2023Q2

141

83.77M

96.89%

-26.04M

2023Q1

107

83.33M

96.42%

-27.69M

2022Q4

106

83.16M

96.22%

-27.74M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Cedarwalk Skincare Ltd

28.64M

25.56%

--

Apr 15, 2024

Zeno Equity Partners LLP

15.34M

13.69%

--

Dec 31, 2024

Waldencast Long-Term Capital LLC

9.31M

8.31%

-7.99M

-46.19%

Nov 19, 2024

Burwell Mountain Trust

7.85M

7%

--

Apr 15, 2024

Main Post Partners, L.P.

6.09M

5.43%

+6.09M

--

Apr 15, 2024

Brousset (Michel)

2.90M

2.59%

--

Apr 15, 2024

Milestones Administradora de Recursos Ltda.

2.20M

1.96%

--

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

1.22M

1.09%

+17.64K

+1.46%

Dec 31, 2024

Verbundene ETFs

Update-Zeit: Fri, May 2

Name

Anteil

iShares Russell 2000 Value ETF

0.01%

Global X Russell 2000 ETF

0%

Proshares Ultra Russell 2000

0%

Avantis US Small Cap Equity ETF

0%

ProShares UltraPro Russell2000

0%

iShares Russell 3000 ETF

0%

Global X Russell 2000 Covered Call ETF

0%

iShares Russell 2000 ETF

0%

ProShares Hedge Replication ETF

0%

iShares Russell 2000 Value ETF

Anteil0.01%

Global X Russell 2000 ETF

Anteil0%

Proshares Ultra Russell 2000

Anteil0%

Avantis US Small Cap Equity ETF

Anteil0%

ProShares UltraPro Russell2000

Anteil0%

iShares Russell 3000 ETF

Anteil0%

Global X Russell 2000 Covered Call ETF

Anteil0%

iShares Russell 2000 ETF

Anteil0%

ProShares Hedge Replication ETF

Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

Waldencast PLC

2.720USD

Waldencast PLC

2.720

Übersicht

Unternehmen